Phenylacetic acid (PAA) represents a substructure of a class of nonsteroidal anti-inflammatory carboxylic acid-containing drugs capable of undergoing metabolic activation in the liver to acylcoenzyme A (CoA)-and/or acyl glucuronide-linked metabolites that are proposed to be associated with the formation of immunogenic, and hence potentially hepatotoxic, drug-protein adducts. Herein, we investigated the ability of PAA to undergo phenylacetyl-S-acyl-CoA thioester (PA-CoA)-mediated covalent binding to protein in incubations with freshly isolated rat hepatocytes in suspension. Thus, when hepatocytes were incubated with phenylacetic acid carboxy-14 C (100 M) and analyzed for PA-CoA formation and covalent binding of PAA to protein and over a 3-h time period, both PA-CoA formation and covalent binding to protein increased rapidly, reaching 1.3 M and 291 pmol equivalents/mg protein after 4 and 6 min of incubation, respectively. However, the covalent binding of PAA to protein was reversible and decreased by 72% at the 3-h time point. After 3 h of incubation, PAA was shown to be metabolized primarily to phenylacetyl-glycine amide (84%). No PAA-acyl glucuronide was detected in the incubation extracts. PA-CoA reacted readily with glutathione in buffer, forming PA-Sacyl-glutathione; however, this glutathione conjugate was not detected in hepatocyte incubation extracts. Coincubation of hepatocytes with lauric acid led to a marked inhibition of PA-CoA formation and a corresponding inhibition of covalent binding to protein. SDS-polyacrylamide gel electrophoresis analysis showed the formation of two protein adducts having molecular masses of ϳ29 and ϳ33 kDa. In summary, PA-CoA formation in rat hepatocytes leads to the highly selective, but reversible, covalent binding to hepatocyte proteins, but not to the transacylation of glutathione.
An on-going concern exists over the association of idiosyncratic allergic reactions and the clinical use of some carboxylic acid-containing drugs (Zimmerman, 1994; Boelsterli, 2002) . The chemical structure of phenylacetic acid (PAA) (Fig. 1) represents a substructure of a class of nonsteroidal anti-inflammatory drugs that have been associated with severe, and sometimes fatal, hepatotoxicity in humans (Zimmerman, 1994; Hunter et al., 1999; Boelsterli, 2003) . An approach to understanding this toxic phenomenon has been through investigations on the metabolic activation and covalent protein binding properties of chemically reactive drug metabolites.
The metabolic activation of drugs is a topic of important toxicologic concern because of the potential of some drugs to form reactive metabolites that can covalently modify macromolecules in the body, causing immune-based idiosyncratic toxicities (Baillie, 2006; Uetrecht, 2008) . These toxicities sometimes are caused from the haptenization of protein that leads to a "triggering" event in the immune system of hypersensitive individuals. These immunologic-based toxic reactions show a very low incidence of 1 in 1000 or even 1 in 100,000 patients. This topic is of major significance in the pharmaceutical industry because there have been several drugs that have been withdrawn from the market for this reason and because there are almost no animal models available today to be able to predict toxic interactions of drugs with the human immune system (Uetrecht, 2008) . Experimental approaches used to assess drugs or drug candidates for their ability to undergo metabolic activation range from glutathione (GSH) trapping of reactive intermediates to covalent binding of drug-related radioactivity to protein (Baillie, 2006) . However, even though drug metabolism scientists are becoming increasingly successful at identifying GSH and protein adducts and determining probable structures of reactive intermediates, we still do not understand why an individual develops a toxic reaction to a certain drug.
For a number of carboxylic acid-containing drugs associated with adverse allergic reactions, the toxicity is proposed to be linked to the metabolic activation of the carboxylic acid moiety through the formation of chemically reactive acyl glucuronides and/or acyl-coenzyme A (CoA) thioesters (Boelsterli, 2002; Skonberg et al., 2008) , leading to the formation of immunogenic drug-protein adducts (Uetrecht, 2008) . In the current study, the role of the chemically reactive acyl-CoA thioester metabolite in the formation of covalent adducts to hepatocyte protein was addressed. Acyl-CoA thioester intermediary metabolites of acidic drugs are more electrophilic (Huxtable, 1986) than their corresponding acyl glucuronide derivatives and are increasingly being investigated for their contribution to the transacylation of GSH and protein (Sallustio et al., 2000; Li et al., 2002a,b; Sidenius et al., 2004; Grillo et al., 2008) .
Results from in vivo studies on the metabolic fate of PAA across species have shown that the compound can form conjugates with glutamine, glycine, ornithine, taurine, and/or glucuronic acid, and where the relative amount of the varied PAA conjugates produced is species-dependent (James et al., 1971) . In rat and human, PAA is known to be metabolized, through the phenylacetyl-S-acyl-coenzyme A thioester (PA-CoA) intermediary metabolite, almost entirely to the amino acid conjugates phenylacetylglycine amide (PA-gly) ( Fig. 1 ) and phenylacetylglutamine, respectively, which are excreted in urine (Ambrose et al., 1933; Dastur and Du Ruisseau, 1961; Jones, 1982) . Because PAA has not been shown to undergo metabolism by acyl glucuronidation in rat, nor is it known to undergo cytochrome P450-mediated metabolic activation to chemically reactive electrophiles, we used it in the present studies as a metabolism route-selective tool compound for focusing on the role of acyl-CoA formation on the covalent binding of the PAA-type structural moiety to rat hepatocyte protein.
Therefore, the primary objective of the present studies was to investigate the role of PA-CoA formation in the transacylation of rat hepatocyte protein leading to the formation of PAA protein adducts. In these mechanistic studies, freshly isolated rat hepatocyte incubation methods, semiautomated covalent protein binding techniques, SDSpolyacrylamide gel electrophoresis (PAGE) analysis, and sensitive liquid chromatography/tandem mass spectrometry (LC/MS/MS) metabolite detection methods were used. We also performed experiments to examine the chemical reactivity of PA-CoA with GSH forming PA-S-acyl-glutathione (PA-SG) in buffer, and also to evaluate the formation of PA-SG that might occur in incubations of PAA with rat hepatocytes.
Materials and Methods
Materials. PAA, PA-CoA, lauric acid sodium salt, carbamazepine (CBZ), HEPES, GSH, and phenylacetic acid carboxy-14 C ([1-14 C]PAA, 10.7 mCi/ mmol) were obtained from Sigma-Aldrich (St. Louis, MO). Naphthalenebenzene-UL-14 C (31.3 mCi/mmol) was purchased from GE Healthcare (Little Chalfont, Buckinghamshire, UK). Rat liver microsomes were purchased from XenoTech, LLC (Lenexa, KS). All the solvents used for mass spectrometric analyses were of chromatographic grade. Authentic PA-gly and PA-SG standards were synthesized as described below. Stock solutions of PAA, PA-gly, PA-CoA, PA-SG, and lauric acid were dissolved in a mixture consisting of acetonitrile and water (pH ϳ5, 1:1, v/v). Stock solutions of authentic PA-CoA and PA-SG standards (1 mM) were stored frozen (Ϫ20°C) and kept cold (on ice) when used during experiments. All the materials used for SDS-PAGE analysis were purchased from Bio-Rad (Hercules, CA).
Instrumentation and Analytical Methods. The PAA conjugates, PA-CoA, PA-gly, and PA-SG were characterized by LC/MS/MS on a Thermo Fisher TSQ Quantum Discovery Max mass spectrometer (Thermo Fisher Scientific, Waltham, MA) linked to an Agilent Technologies (Palo Alto, CA) 1100 high-performance liquid chromatograph (HPLC) and a CTC HTS PAL autosampler (LEAP Technologies, Carrboro, NC). LC/MS/MS analysis of PACoA was performed with a Phenomenex (Torrance, CA) Luna, 5-m, C18(2), 100 Å, 150 ϫ 2.00-mm reverse-phase column. The mobile phase used for the analysis of PA-CoA was aqueous ammonium acetate (10 mM, pH 6.0, solvent A) and acetonitrile (solvent B). Gradient elution was achieved by increasing solvent B from 0 to 95% over 13 min at a mobile phase flow rate of 0.3 ml/min.
Chromatographic resolution of PA-SG and PA-gly derivatives for qualitative analysis was achieved with a Shiseido (Tokyo, Japan) Capcell, Pak-AQ, C-18 column (4.6 ϫ 250 mm, 3 m). The mobile phase consisted of 0.1% aqueous formic acid (solvent C) and acetonitrile with 0.08% formic acid (solvent D) run at a constant flow rate of 1 ml/min. The solvent gradient was initially held at 0% solvent D for 5 min and increased linearly to 70% solvent D over another 45 min, kept at 70% solvent D for an additional 4 min, and then immediately decreased to 0% solvent D over 0.1 min, where it was held constant at 0% solvent D for 6 min before the next sample injection (25 l). Radioactive peaks were detected using a ␤-RAM detector (model 3; IN/US Systems, Inc., Tampa, FL) linked to an Agilent Technologies HPLC instrument, using the same chromatographic method as described directly above and with sample injection volumes of 45 l. LC/MS/MS analysis was performed with a Phenomenex Luna, 5 m, C18(2), 100 Å, 150 ϫ 2.00-mm reversephase column for the quantification of PA-SG and PA-gly derivatives formed in incubations of hepatocytes with [1-14 C]PAA. The mobile phase used for this analysis consisted of solvent C and solvent D, as described above, with gradient elution achieved by increasing solvent D from 0 to 95% over 13 min at a mobile phase flow rate of 0.3 ml/min. For all the LC/MS/MS analyses, electrospray ionization was used with the needle potential held at 4.5 kV. MS/MS conditions used were 2 mTorr argon collision gas and 25 eV collision potential. Positive ion mode full scan (m/z 50 -1200) was conducted with a scan time of 0.73 s and source collision energy of 10 V. Xcalibur software (version 2.0; Thermo Fisher Scientific) was used to acquire all the data.
1 H NMR spectra were recorded on a Bruker (Bruker Daltonics, Billerica, MA) Avance II spectrometer operating at 500 MHz and using a 5-mm, general purpose, cryogenically cooled probe (QNP CryoProbe; Bruker BioSpin Corporation, Fremont, CA). Chemical shifts are reported in parts per million as referenced to the residual solvent peak (2.49 ppm for 2 H 6 -dimethyl sulfoxide). Synthesis of PA-SG and PA-gly. The synthesis of both PA-SG and PA-gly was performed by a conventional procedure using ethyl chloroformate (Stadtman, 1957) . In brief, to PAA (1.6 mmol, 272 mg), dissolved in anhydrous tetrahydrofuran (THF, 25 ml), was added, at room temperature and while stirring, triethylamine (1.6 mmol, 220 l) followed by ethyl chloroformate (1.6 mmol, 160 l). After 30 min of continued stirring, the precipitate that formed (triethylamine hydrochloride) was removed by passing the reaction mixture through a glass funnel fitted with a glass wool plug. The filtered mixture then was added to a solution containing KHCO 3 (1.6 mmol, 160 mg) and GSH (3.3 mmol, 1 g), for the synthesis of PA-SG, or glycine (13.3 mmol, 1 g), for the synthesis of PA-gly, in distilled water (10 ml, adjusted to pH 8.1 with NaOH [1N]) and THF (15 ml). The solution was stirred continuously under an atmosphere of nitrogen gas at room temperature for 1 h, after which the reaction was terminated by the addition of concentrated HCl (8 drops). The THF then was removed by evaporation under reduced pressure, and the remaining aqueous phase was extracted with ethyl acetate (4 ϫ 50 ml). Residual ethyl acetate was removed by evaporation under reduced pressure at room temperature. Both PA-SG and PA-gly derivatives were present as white precipitates in their respective acidic solutions and were collected by vacuum filtration through a glass-fritted filter, followed by two aqueous HCl (0.1 N, 100 ml) washes of the precipitates by vacuum filtration to wash away residual KHCO 3 , GSH, or glycine. The precipitates then were scraped off the glass vacuum filter and placed into preweighed glass vials (8-ml volume), and the residual ethyl acetate was removed by evaporation under a stream of N 2 gas at room temperature (2 h). The yields of PA-SG and PA-gly were determined to be 12 and 30%, respectively. PA-SG thioester eluted at a retention time of 25.5 min and showed no detectable impurities when analyzed by both positive and negative ion LC/MS scan modes using the 60-min reverse-phase gradient elution method as described above. PA-SG: whereas CBZ eluted at 7.4 min. The concentration of PA-CoA was determined from a linear standard curve generated from PA-CoA/CBZ peak area ratios. ϩ m/z 237 to m/z 194 for CBZ in the positive ion mode and using the 13-min (solvent C and solvent D containing mobile phase) chromatographic method described above. Authentic PA-SG standard eluted at a retention time of 5.8 min; standard PA-gly eluted at a retention time of 4.2 min; and CBZ eluted at 7.6 min. The concentrations of PA-SG and PA-gly were determined from the corresponding linear standard curves generated from PA-SG/CBZ or PA-gly/ CBZ peak area ratios, respectively.
In Vitro Studies with Rat Hepatocytes. Freshly isolated hepatocytes were prepared and incubated according to the method of Moldéus et al. (1978) . Hepatocytes were isolated from Sprague-Dawley rats (250 -300 g, male; Charles River Laboratories, Inc., Wilmington, MA), and greater than 90% viability was achieved as assessed by trypan blue exclusion testing. Incubations of hepatocytes (2 million viable cells/ml) with [1-
14 C]PAA were performed in Krebs-Henseleit buffer, pH 7.4, in 8-ml glass vials. Hepatocytes were warmed to 37°C in a water bath under an atmosphere of 95% O 2 and 5% CO 2 for 15 min before initiating incubations with [1-
14 C]PAA. Incubations were performed in triplicate (1-ml total incubation volume) for each experiment and were conducted with continuous rotation (10 rpm) at a 75°angle and under an atmosphere of 95% O 2 and 5% CO 2 at 37°C in a VWR (West Chester, PA) model 1927 humidified cell culture incubator. Cells then were incubated with [1-
14 C]PAA for up to 3 h for time-dependent experiments and for 10 min for [1-
14 C]PAA concentration-dependent and enzyme inhibition studies. Sample Processing for Metabolite Detection. For the analysis of PA-CoA formation, aliquots (200 l) from rat hepatocyte incubations were taken and added to microcentrifuge tubes (2 ml) containing quench solution (200 l, acetonitrile, 0.2 M CBZ internal standard), followed by the addition of hexane (400 l). The samples then were capped, vortex-mixed (1 min), microcentrifuged (14,000g, 5 min), and finally aliquots (300 l) of the aqueous layer (lower layer) transferred to HPLC autosampler vials for LC/MS/MS analysis as described above. For the analysis of PA-SG and PA-gly derivatives, aliquots (200 l) from rat hepatocyte incubations were taken and added to microcentrifuge tubes (2 ml) containing quench solution (200 l, acetonitrile, 3% formic acid, 0.2 M CBZ internal standard). The samples then were capped, vortex-mixed (1 min), microcentrifuged (14,000g, 5 min), and aliquots (300 l) of the supernatant transferred to HPLC autosampler vials for LC/ MS/MS and HPLC/radioactivity analysis of PA-SG and PA-gly derivatives as described above.
Covalent Binding Determination. For time-dependent covalent binding studies (n ϭ 4) performed in rat hepatocytes, 100-l aliquots of incubations were taken at 0, 1, 2, 4, 6, 8, 10, 20, 30, 60, 120 , and 180 min and transferred to a 96-well plate (2-ml well volume) containing 400 l of acetone/well. The samples then were vortex-mixed (30 s) and washed using the Brandel Semiautomated Cell Harvester System (48-Sample, SemiAuto Harvester, Brandel Inc., Gaithersburg, MD) by a slightly modified method adapted from a recently published procedure for covalent binding studies conducted with liver microsome preparations (Day et al., 2005) . Thus, the precipitated protein was trapped onto a Whatman (Clifton, NJ) glass fiber filter mat, washed with 80% acetone/water (10 ml, v/v), and treated further by 10 washes with 80% methanol/water (1 ml, v/v). The captured washed proteins on the glass fiber filter mat sections then were transferred to another 96-well plate (2-ml well volume) and treated with KOH (1 ml, 1 N) for 1 h in a heated water bath (95°C) with moderate horizontal shaking. The hydrolyzed samples were allowed to cool on ice (15 min), and then aliquots (20 l) were taken for protein concentration determination using the bicinchoninic acid protein assay (Pierce Biotechnology, Inc., Rockford, IL). Aliquots (450 l) of the hydrolyzed solutions were taken for liquid scintillation counting (Tri-Carb 2800TR Liquid Scintillation Analyzer; PerkinElmer Life and Analytical Sciences, Waltham, MA) and added to scintillation vials (6 ml) containing Pico-Fluor 40 liquid scintillant (5 ml; PerkinElmer Life and Analytical Sciences with rat hepatocytes (2 ϫ 10 6 cells/ml, triplicate incubations) for an incubation time of 10 min and then processed for the analysis of PA-CoA, PA-SG, and covalent binding to protein as described above. These experiments were performed to determine the appropriate concentration of [1-
14 C]PAA for use in subsequent enzyme inhibition studies as described below.
Inhibition Studies. To inhibit PA-CoA formation and to determine the subsequent effects on covalent binding of [1- 14 C]PAA to protein, hepatocytes were incubated with increasing concentrations of lauric acid (0, 62.5, 125, and 250 M) for 5 min before the addition of [1-14 C]PAA (100 M) as described above. After 10 min of incubation at 37°C in a shaking incubator (set at the lowest shaking speed of 30 rpm) and under an atmosphere of 95% O 2 and 5% CO 2 , aliquots of the incubations were taken for PA-CoA quantification, PA-SG detection, and covalent binding to protein determination and processed as described above.
SDS-PAGE. For SDS-PAGE analysis, aliquots (200 l) from hepatocyte incubations, obtained from time course and inhibition experiments described above, were quenched with 100% acetonitrile (2 ml) and microcentrifuged (14,000g, 5 min). The supernatants then were removed, and the pellets were washed by microcentrifugation three more times with acetonitrile (2 ml) to remove the unbound radioactivity. The final supernatants were shown not to contain radioactivity when 0.5-ml aliquots were analyzed by scintillation counting as described above (data not shown). SDS-PAGE was performed using the Mini Protean 3 Cell electrophoresis system (Bio-Rad), where 50 g of protein was loaded onto 10% Tris-HCl polyacrylamide gels (7.0 cm height, 8.3 cm width, 1.0 mm thickness) per well and electrophoresis was conducted for 1 h at 120 V. The gels were stained for protein with Coomassie Blue R-250 for 2 min and then destained with a solution containing distilled water, 10% glacial acetic acid, and 20% methanol for 30 min, followed by treatment with distilled water (30 min). The gels were dried using the model 3 Gel dryer (1 h; Bio-Rad) and then exposed to Fuji Film Imaging Plates (Fuji Film, Tokyo, Japan) for 1 month. Captured phosphorimages of radiolabeled proteins were analyzed using Fuji Film FLA-5100 Bio-Imaging Analyzer and Multigauge 3.0 software (Fuji Film).
Degradation of PA-SG in Rat Hepatocyte Incubations. An experiment was performed to assess the metabolic stability of PA-SG thioester (1 M) in incubations with rat hepatocytes (2 ϫ 10 6 cells/ml). Aliquots (200 l) from the incubations (2-ml volume, n ϭ 3) were taken at 0.2, 1, 2, 4, 6, 8, and 10 min, added to quench solution, and processed for the LC/MS/MS detection of PA-SG as described above. Analysis of the amount of PA-SG remaining in the incubation was determined by LC/MS/MS MRM detection and using a linear standard curve of PA-SG (MH ϩ m/z 426 to m/z 279)/CBZ (MH ϩ m/z 237 to m/z 194) peak area ratios.
Microsomal Covalent Binding Assay. Rat liver microsome covalent binding to protein assessment was performed with [1-14 C]PAA (100 M). Incubations with rat liver microsomes (0.2 ml, 1 mg/ml protein) (BD Gentest, Woburn, MA) were conducted in phosphate buffer (0.1 M, pH 7.4) for 1 h at 37°C and were performed in the absence of NADPH (used as a negative control) or in the presence of NADPH (1 mM) with or without GSH (10 mM). Covalent binding of [1-
14 C]PAA radioactive equivalents to protein was measured using the semiautomated protein washing procedure using the Brandel Inc. (Gaithersburg, MD) cell harvester according to the method described by Day et al. (2005) .
Reactions of PA-CoA with GSH in Buffer. Incubations (0.5 ml total volume, n ϭ 3 incubations/time point) containing PA-CoA (1 M) were performed in phosphate buffer (0.1 M, pH 7.4) at 37°C with GSH (10 mM). Incubations were stopped at 0, 2, 4, 6, 8, 10, 20, 30, and 60 min by the addition of quench solution (acetonitrile containing 3% formic acid and 0.2 M CBZ, 0.5 ml), and aliquots (0.4 ml) of the quenched solution were transferred to HPLC autosampler vials and analyzed for PA-SG and PA-CoA concentrations by LC/MS/MS as described above.
Results
Identification of PA-CoA. Analysis of rat hepatocyte incubation extracts by LC/MS/MS MRM detection allowed for the identification of PA-CoA formed in hepatocyte incubations with [1-14 C]PAA (100 M) (Supplemental Data Fig. 1) , where it eluted with a retention time of 5.4 min and where it was shown to coelute with the authentic PA-CoA standard. The transition used for this analysis was MH ϩ m/z 886 to m/z 379, chosen because it is the major fragmentation pathway for authentic PA-CoA as assessed by positive ion LC/MS/MS CID of the MH ϩ ion (Fig. 2B) . LC/MS/MS analysis of biologically formed PA-CoA by CID of the MH ϩ ion at m/z 886 provided a product ion spectrum identical to the product ion spectrum of the authentic PACoA standard and consistent with its chemical structure ( Fig. 2A) .
Identification of PA-gly Amide. Reverse-phase LC/MS/MS analysis of incubation extracts showed the presence of [1-
14 C]PA-gly in incubations of [1-14 C]PAA (100 M) with rat hepatocytes, and which coeluted with authentic PA-gly standard at a retention time of 25.0 min (Supplemental Data Fig. 2) . The transition used for this analysis was MH ϩ m/z 194 to m/z 91, chosen because it is the major fragmentation pathway for the authentic standard as assessed by positive ion LC/MS/MS CID of the MH ϩ ion (Fig. 3B) . LC/MS/MS analysis of biologically formed PA-gly by CID of the MH ϩ ion at m/z 194 provided a product ion spectrum identical to the product ion spectrum of the authentic PA-gly standard and consistent with its chemical structure (Fig. 3A) . Analysis of hepatocyte incubation extracts by HPLC/radioactivity detection showed [1-
14 C]PA-gly to be the only radioactive metabolite formed, and where 84% of the total radioactivity detected at the 180-min time point was in the form of 14 C]PAA (100 M) was incubated with hepatocytes, the formation of PA-CoA was rapid and reached a maximum concentration of 1.3 Ϯ 0.1 M after 4 min of incubation, and then decreased in a linear fashion to almost undetectable levels (0.06 nM) at the 3-h time point (Fig. 4A) . From these same incubations, covalent binding to protein was also shown to be rapid, reaching 291 Ϯ 20 pmol equivalents/mg protein after 6 min of incubation. A maximum of 308 Ϯ 30.0 pmol equivalents/mg protein was detected at the 10-min time point; however, this amount was not statistically significant from that measured at the 6-min time point. After the 10-min time point, covalent binding of [1- 14 C]PAA to protein decreased in a fairly linear fashion to 80.5 Ϯ 12.2 pmol equivalents/mg protein at the 180-min time point. From these same incubations, we examined extracts for the time course of disappearance and appearance of PAA and PA-gly, respectively, over the 180-min incubation period. Results showed that PAA was metabolized primarily to PAgly in a nearly linear fashion, and where ϳ92% of the substrate was cleared and 84 Ϯ 4.5 M PA-gly was formed by the 180-min time point (Fig. 4B) . No PAA-acyl glucuronide was detected in these incubation extracts when analyzed by both positive and negative ion scanning LC/MS for the MH ϩ ion at m/z 313 and the [M-H] Ϫ ion at m/z 311, respectively (results not shown), which is consistent with reports indicating a lack of formation of this metabolite in vivo in rat (James et al., 1971) .
SDS-PAGE. Analysis of washed protein precipitates obtained from [1-
14 C]PAA (100 M) rat hepatocyte incubations (triplicate incubation samples combined from one of the replicate experiments as described above) by SDS-PAGE revealed the presence of two radiolabeled protein bands having molecular masses of ϳ29 and ϳ33 kDa (Fig. 5A) . The 33-kDa protein adduct was formed as early as the 0.2-min time point of incubation but was short-lived and not detectable after 8 min of incubation. The captured phosphorimage shows a second radiolabeled protein adduct band, of similar intensity to the 33-kDa band (visual estimation), at a molecular mass of ϳ29 kDa, which was present from the 1-min to the 180-min time point. The Fig. 5B . The range of covalent binding to protein was between 180 and 310 pmol equivalents/mg protein from 1 to 120 min of incubation, respectively, and was ϳ70 pmol equivalents/mg protein at the 0.2-and 180-min time points, which corresponds to the faint bands observed on the phosphorimage occurring at those time points. A Coomassie Blue-stained one-dimensional SDS-PAGE gel corresponding to the phosphorimage (Fig. 5A) is shown in Fig. 4 of the supplemental data, which shows uniform (Fig. 6) . No PA-SG derivative was detected at any concentration of PAA tested (data not shown).
Inhibition Studies. To determine the importance of PA-CoA formation in the metabolic activation of [1-14 C]PAA, the effect of inhibition of PA-CoA formation on the covalent binding of PAAderived radioactivity to hepatocyte protein was examined. Inhibition experiments were performed with 100 M [1-
14 C]PAA in incubations with rat hepatocytes (2 ϫ 10 6 cells/ml, 10 min) in the absence or presence of increasing concentrations of lauric acid, an inhibitor of xenobiotic-acyl-CoA formation (Tracy et al., 1993) . Results showed that coincubation of hepatocytes with 6.25, 125, and 250 M lauric acid led to a 86 Ϯ 1, 96 Ϯ 3, and 100 Ϯ 0% inhibition PA-CoA formation and a corresponding 71 Ϯ 13, 94 Ϯ 5, and 95 Ϯ 6% inhibition of covalent binding of [1- 14 C]PAA-derived radioactivity to protein, respectively (Fig. 7) .
Rat Liver Microsomal Covalent Binding. Results from covalent binding studies in rat liver microsomes showed that [1-14 C]PAA (100 M) irreversible binding to protein in the presence of NADPH was barely detectable (5.2 Ϯ 3.8 pmol equivalents/mg protein/h), and where no covalent binding to protein was detected in the absence NADPH, nor in the presence of NADPH fortified with GSH (10 mM).
The positive control [
14 C]naphthalene became covalently bound to protein in an NADPH fashion at a level of 1113 Ϯ 174 pmol equivalents/mg protein/h, which is within the range of what has been reported previously (Day et al., 2005) .
Identification of PA-SG Thioester. The PA-SG derivative was detected in extracts from incubations of 1 M PA-CoA with 10 mM GSH in 0.1 M potassium phosphate buffer (pH 7.4, 37°C), where it coeluted with its authentic standard at a retention time of 25.5 min (Supplemental Data Fig. 6 ). The MRM transition used for the analysis of PA-SG was MH ϩ m/z 426 to m/z 194, chosen because it is a major fragmentation pathway for the authentic standard as assessed by positive ion LC/MS/MS CID of the MH ϩ ion at m/z 426 (Fig. 8B ). LC/MS/MS analysis of PA-SG formed in these incubations provided a product ion spectrum that showed fragment ions identical to the authentic PA-SG standard and which was consistent with its chemical structure (Fig. 8A) .
Degradation of PA-SG in Incubations with Rat Hepatocytes. The time course of degradation of authentic PA-SG thioester (1 M) in incubations with rat hepatocytes revealed it to be rapidly degraded and completely consumed by the 8-min time point. The degradation t 1/2 was determined to be ϳ1.7 min (Supplemental Data Fig. 7) . The products of PA-SG degradation were not characterized in this experiment; however, the degradation was presumably caused by hydrolysis of PA-SG forming PAA, similar to a report showing the hydrolysis of diclofenac-S-acyl-glutathione to diclofenac in incubations with rat hepatocytes , and not a result of ␥-glutamyltranspeptidase activity, which is known to be negligible in rat liver tissue (Hinchman and Ballatori, 1990) .
Reaction of GSH with PA-CoA in Buffer. Incubation of PA-CoA (1 M) in the presence of GSH (10 mM) in buffer (0.1 M potassium phosphate, pH 7.4, 37°C, 0.5-ml incubation volume) over a 60-min period showed a linear time-dependent transacylation of GSH forming PA-SG at a formation rate of ϳ0.011 nmol/min for the first 10 min of incubation and reached 0.68 M PA-SG after 60 min of incubation (Fig. 9) . The concentration of PA-CoA decreased gradually from the incubation mixture and reached 0.37 M at the 60-min time point. In a separate experiment, where PA-CoA was incubated under the same conditions used above except in the absence of GSH, PA-CoA was determined to be completely stable over the 60-min incubation period (data not shown).
Discussion
Results from the present study provide evidence that PAA undergoes metabolic activation to the reactive transacylating acyl-CoA intermediate, PA-CoA, which mediates the covalent binding of PAA to protein. These results are consistent with an increasing number of reports showing that xenobiotic acyl-CoA thioesters are reactive electrophiles that contribute to covalent binding of carboxylic acid-containing compounds to liver proteins (Sallustio et al., 2000; Li et al., 2002a; Sidenius et al., 2004; Olsen et al., 2005 Olsen et al., , 2007 .
In the current study, PAA was used to represent the potential acyl-CoA-mediated metabolic activation that may be occurring for PAA substructure-containing drugs known to be associated with idiosyncratic hepatotoxicity (Zimmerman, 1994; Boelsterli, 2003) . The metabolism of PAA in rats and humans is simple, where the major metabolites, formed via PA-CoA, are PA-gly and PA-glutamine amino acid conjugates, respectively (Ambrose et al., 1933; Dastur and Du Ruisseau, 1961; Jones, 1982) . Therefore, PAA was a valuable metabolism route-selective tool compound used in the present studies to investigate the potential importance of the acyl-CoA thioester formation on the covalent binding of PAA substructure-containing drugs to hepatocyte protein and GSH.
In the present work, we determined that PA-CoA reacted readily with GSH in phosphate buffer (pH 7.4 and 37°C), leading to the formation of the PA-SG derivative (Figs. 8 and 9 ). However, when we analyzed PAA rat hepatocyte incubation extracts for PA-SG, none of this conjugate could be detected, even with the use of a highly sensitive LC/MS/MS MRM detection method (subnanomolar sensitivity). We did not expect this result because we and others have been able to detect S-acyl-GSH conjugates for a number of carboxylic acid-containing drugs such as clofibric acid (Shore et al., 1995) , zomepirac Olsen et al., 2005) , tolmetin (Olsen et al., 2007) , and ibuprofen (Grillo and Hua, 2008) , which are known to form reactive S-acyl-CoA thioester intermediates. The lack of detection of PA-SG in rat hepatocyte incubation extracts may be in part caused by its rapid clearance from hepatocyte incubations, where PA-SG (1 M) was shown to be completely degraded after 6 min of incubation (degradation t 1/2 of ϳ1.7 min; Supplemental Data Fig. 7) . However, in similar experiments with zomepirac-SG, diclofenac-SG, and ibuprofen-SG thioesters, the degradation rates were also rapid (measured t 1/2 values of 0.8, 1.0, and 4.0 min, respectively) Hua, 2003, 2008; . Another explanation for the lack of detection of PA-SG might be that once PA-CoA is formed, it does not escape from the site(s) of formation into the cytosol or mitochondrial matrix where it would be able to react with pools of GSH. The high degree of selectivity in the formation of hepatocyte PAA protein adducts, as indicated by the SDS-PAGE results (Fig. 5) , would support this proposal. It is noteworthy that these findings indicate that a lack, or low level, of xenobiotic-acyl-GSH adduct detection should not be used to predict no, or a low, potential for xenobiotic-acyl-CoA intermediates to mediate the formation of covalent adducts with hepatocyte protein.
Results from time course experiments showed a very rapid initial increase in PA-CoA formation followed by a rapid increase in covalent binding of radioactive [1- 14 C]PAA equivalents to protein, where maximum levels occurred at the 4-and 6-min time points, respectively (Fig. 4) . These results show the importance of sampling for covalent binding to protein determination at early hepatocyte incubation time points for acyl-CoA-forming compounds. The time course data showing the close association between the concentration of PA-CoA and the amount of covalent binding to protein, as well as the inhibitory effect of lauric acid on both PA-CoA formation and covalent binding, clearly show the role of PA-CoA as the reactive intermediate responsible for the irreversible binding of PAA to hepatocyte protein. These results are similar to results from mechanistic covalent binding studies performed with 2-phenylpropionic acid (2-PPA), an ␣-methyl analog of PAA (Li et al., 2002a) . Data from those experiments, where 2-PPA underwent both acyl-CoA formation and acyl glucuronidation-type metabolism in incubations with rat hepatocytes, showed that 2-PPA- S-acyl-CoA formation was the predominant metabolic pathway, relative to 2-PPA-acyl glucuronide formation, mediating the covalent binding of 2-PPA to hepatocyte protein.
The steady decrease in the concentration of PA-CoA occurring after the 4-min hepatocyte incubation time point can be explained by the corresponding conversion of this intermediate to the glycine-amide derivative, where 84% of the PAA substrate was converted to PA-gly by the 3-h time point (Fig. 4B) . Glycine N-acyltransferase is known to catalyze the conjugation of PA-CoA with glycine in what is often considered a detoxification mechanism for endogenous and exogenous xenobiotic acyl-CoA thioesters that occurs primarily in the matrix of the mitochondrion (James and Bend, 1978; Kølvraa and Gregersen, 1986) . The molecular mass of glycine N-acyltransferase is reported to be ϳ33 kDa (Nandi et al., 1979; Kelley and Vessey, 1992) , which is the molecular mass of the short-lived protein adduct band that we observed in our SDS-PAGE analysis (Fig. 5) . We do not know whether this 33-kDa molecular mass band represents a PAA adduct to the glycine N-acyltransferase enzyme, where active site nucleophilic amino acid residues are present (Lau et al., 1977) . It is noteworthy that a phenylacetyl-enzyme covalent intermediate, formed through a double-displacement mechanism, has been proposed to be unlikely (Nandi et al., 1979) . The molecular mass of phenylacetylCoA ligase is ϳ52 kDa (Mohamed and Fuchs, 1993) ; however, no detectable PAA protein adducts were observed at this molecular mass in the present work. Other rat hepatocyte covalent binding studies have shown that hypolipidemic carboxylic acid drugs, including nafenopin, bezafibrate, and MEDICA 16, were able to transacylate membrane and cytosolic liver proteins in incubations with cultured rat hepatocytes (Hertz and Bar-Tana, 1988) . Their results showed that the common selective hepatocyte protein adducts weighed 32, 52, 56, and 72 kDa, and where protein acylation was attributed to the formation of the corresponding chemically reactive acyl-CoA thioesters.
In the present work, we did not determine whether the covalent adducts formed between PAA and protein were linked through amide, ester, or thioester linkages. However, data from in vitro studies with 2-PPA, the ␣-methyl analog of PAA, showed that protein adducts formed on reaction of 2-PPA-CoA with bovine serum albumin were linked via O-tyrosine-ester (44%), amide (41%), and thioester bonds (18%; Li et al., 2002b) . Recent in vitro studies with naproxen-S-acylCoA, in reactions with human serum albumin, showed that the major amino acid adduct was to the free cysteinyl thiol, Cys34 (Olsen et al., 2002) . In addition, Sallustio et al. (2000) found that nafenopin-S-acylCoA, in incubations with human liver microsomes, formed protein adducts primarily linked via thioester and amide bonds. In another recent study, myristic acid, via myristyl-CoA, was shown to form 18 covalently modified proteins in incubations with cultured rat hepatocytes (Rioux et al., 2002) . The protein adducts ranged in molecular mass from 10 to 120 kDa and were primarily linked by oxygen ester and thioester bonds. Just as in the present studies, protein adducts with molecular masses of ϳ29 and ϳ33 kDa were also detected in that study, although their identities were not determined.
The PAA protein adducts detected in the present studies were shown to be rapidly formed and then gradually removed, presumably by enzyme-mediated hydrolysis, from intact viable hepatocytes (Fig.  4A ). This efficient "repair" may correspond to a lack of PAA-induced liver toxicity (Dastur and Ruisseau, 1961) . The dynamic nature of xenobiotic protein covalent modification and the roles of adduct stability, repair, and turnover in cell toxicity have recently been considered (Lin et al., 2008) . It was proposed that the low cytotoxicity of chemically reactive electrophilic compounds might reflect a facile repair that results in transient protein covalent binding, which does not lead to the "turning on" of damage-signaling pathways that lead to cell death. The importance of acyl-CoA-mediated transacylation of protein and the generation of an adaptive immune system-mediated allergic reaction might also depend on the stability of the linkage (Park et al., 1998) . For example, S-or O-acyl-linked protein adducts may not be stable enough to survive the process of antigen presentation by the dendritic cells or other antigen-presenting cells to be able to "trigger" an immune response (Uetrecht, 2008) . However, drugs such as penicillin and halothane, which directly or via cytochrome P450-mediated metabolism to a reactive intermediate, respectively, lead to the formation of immunogenic N-amide-linked protein adducts in humans (Levine 1966; Kenna et al., 1988) .
In summary, freshly isolated rat hepatocytes were used herein to successfully show the importance of metabolic activation of PAA by acyl-CoA formation leading to covalent binding to protein. These results may indicate the potential for other drugs having the PAA-type substructure to undergo similar acyl-CoA-mediated metabolic activation and subsequent covalent binding to protein. Because the covalent binding to protein was reversible, these results indicate the importance of assessing the covalent binding to protein within the early minutes of hepatocyte incubations when evaluating the full range of covalent binding potential for acidic drugs that undergo metabolism by acylCoA formation. Finally, from these results, we propose that metabolic activation of PAA substructure containing drugs by acyl-CoA formation will lead to covalent binding to hepatic protein and could contribute to the potential hepatotoxicity of this chemical class of drugs.
